Speaker selection has traditionally followed a familiar pattern: identify well-known experts, validate credentials, and build programs around visibility and reputation. While this approach checks many boxes, it often misses the most important question:
Neolytica blends KOL sentiment analysis, behavioral insights, and network mapping to reveal influential local clinicians, improving pharma engagement and strategy.
Medical and commercial teams rarely disagree on objectives. Both want relevant conversations, credible science, and measurable impact. Yet in practice, alignment often breaks down, not because of intent, but because teams are working with partial
Field and medical teams spend countless hours planning who to meet, what to discuss, and how to advance scientific conversations. But despite all this effort, one question keeps coming back:
In medical affairs and field engagement, timing and context often decide the quality of every conversation. You can have the best data, the strongest story, and the right expert, but if the dialogue doesn’t align
Scientific engagement works best when it’s synchronized with how HCPs are thinking and talking today, not last quarter. That’s why digital sentiment, the tone and direction of expert conversations across professional forums, congress backchannels, preprints,
KEE targeting has evolved. Version 1.0 was spreadsheets of “top names.” Version 2.0 chased digital activity, who posts, where, and how often. KEE Targeting 3.0 goes further: it connects role, behavior, and impact to reveal
Not all influence looks the same. Some experts write guidelines, others steer trial sites, and a growing cohort shapes thinking online. Effective KEE targeting starts with segmentation that goes beyond “who is famous” to “who
Volume isn’t the same as influence. Some Key External Experts shape clinical thinking without posting daily threads or dominating conference panels. They publish pivotal guidelines, lead multi‐center studies, advise payer committees, and move their peers
Identifying and engaging Key Opinion Leaders (KOLs) requires more than just counting followers or publication citations. With rapid digitalization and innovation in the healthcare space, organizations need an “Expert Universe.”
Digital Opinion Leaders (DOLs) have emerged as critical partners for healthcare organizations seeking to amplify scientific insights, foster clinician trust, and accelerate product adoption.
Effective competitive strategy in healthcare hinges on timely, actionable insights. Traditional market research (sales data, prescription volumes, and clinical trial results) often lags behind real-time shifts in clinician and patient perceptions. Social listening fills this